Payment overview · 2025
General Payments
$3,248.16
89 reported records · 22 companies
Healthcare provider profile · identity verified
Ignatius Lau, M.D.
Allopathic & Osteopathic Physicians|Surgery|Vascular Surgery · NEW YORK, NY · NPI 1407210529
Verified facts
What the public records show
CMS Open Payments records show Ignatius Lau, M.D. received $3,248.16 in general payments during 2025 across 89 reported records.
Abbott Laboratories accounted for 20.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 41 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Abbott Laboratories | Unresolved — no canonical attribution shown | $678.28 | 20.9% | 19 | 2025 |
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $435.28 | 13.4% | 8 | 2025 |
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$402.32 | 12.4% | 25 | 2025 |
| Cagent Vascular INC | Unresolved — no canonical attribution shown | $323.55 | 10.0% | 2 | 2025 |
| Bard Peripheral Vascular, Inc. | Unresolved — no canonical attribution shown | $315.26 | 9.7% | 5 | 2025 |
| Penumbra, Inc. | Unresolved — no canonical attribution shown | $301.96 | 9.3% | 2 | 2025 |
| AngioDynamics, Inc. | Unresolved — no canonical attribution shown | $144.08 | 4.4% | 4 | 2025 |
| W. L. Gore & Associates, Inc. | Unresolved — no canonical attribution shown | $136.01 | 4.2% | 5 | 2025 |
| Urgo Medical North America, LLC | Unresolved — no canonical attribution shown | $53.57 | 1.6% | 2 | 2025 |
| Koya Medical, Inc. | Unresolved — no canonical attribution shown | $53.43 | 1.6% | 3 | 2025 |
| Inari Medical, Inc. | Unresolved — no canonical attribution shown | $50.07 | 1.5% | 1 | 2025 |
| Smith+Nephew, Inc. | Unresolved — no canonical attribution shown | $46.67 | 1.4% | 1 | 2025 |
| Stryker Corporation | Unresolved — no canonical attribution shown | $46.01 | 1.4% | 2 | 2025 |
| Organogenesis Inc. | Unresolved — no canonical attribution shown | $44.71 | 1.4% | 1 | 2025 |
| Reflow Medical Inc | Unresolved — no canonical attribution shown | $39.16 | 1.2% | 2 | 2025 |
| Shockwave Medical, Inc | Unresolved — no canonical attribution shown | $33.69 | 1.0% | 1 | 2025 |
| Baylis Medical Technologies Inc. | Unresolved — no canonical attribution shown | $29.10 | 0.9% | 1 | 2025 |
| Tactile Systems Technology Inc | Unresolved — no canonical attribution shown | $25.55 | 0.8% | 1 | 2025 |
| CORDIS US CORP. | Unresolved — no canonical attribution shown | $25.13 | 0.8% | 1 | 2025 |
| MIMEDX Group, Inc. | Unresolved — no canonical attribution shown | $23.52 | 0.7% | 1 | 2025 |
| Becton, Dickinson and Company | Unresolved — no canonical attribution shown | $23.19 | 0.7% | 1 | 2025 |
| Cook Medical LLC | Unresolved — no canonical attribution shown | $17.62 | 0.5% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $3,248.16 | 89 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| ESPRIT Normalized: esprit |
Device | Abbott Laboratories | $523.92 | 12 | 2025 |
Source payment records
|
|||||
| Serrantor Normalized: serrantor |
Device | Cagent Vascular INC | $323.55 | 2 | 2025 |
Source payment records
|
|||||
| General - Vascular Intervention Normalized: general vascular intervention |
Device | Boston Scientific Corporation | $316.83 | 5 | 2025 |
Source payment records
|
|||||
| RotarexS 6 F x 135 cm Normalized: rotarexs 6 f x 135 cm |
Device | Bard Peripheral Vascular, Inc., Becton, Dickinson and Company | $170.57 | 2 | 2025 |
Source payment records
|
|||||
| Indigo System Normalized: indigo system |
Device | Penumbra, Inc. | $154.85 | 1 | 2025 |
Source payment records
|
|||||
| Penumbra System Normalized: penumbra system |
Device | Penumbra, Inc. | $147.11 | 1 | 2025 |
Source payment records
|
|||||
| AURYON LASER SYSTEM 100-120 VAC Normalized: auryon laser system 100 120 vac |
Device | AngioDynamics, Inc. | $144.08 | 4 | 2025 |
Source payment records
|
|||||
| DIAMONDBACK PERIPHERAL Normalized: diamondback peripheral |
Device | Abbott Laboratories | $140.52 | 6 | 2025 |
Source payment records
|
|||||
| COVERA Normalized: covera |
Device | Bard Peripheral Vascular, Inc. | $133.91 | 3 | 2025 |
Source payment records
|
|||||
| IN.PACT ADMIRAL Normalized: in pact admiral |
Device | Medtronic, Inc. | $83.18 | 3 | 2025 |
Source payment records
|
|||||
| TURBOHAWK Normalized: turbohawk |
Device | Medtronic, Inc. | $79.25 | 3 | 2025 |
Source payment records
|
|||||
| CT THROMBECTOMY SYSTEM KIT Normalized: ct thrombectomy system kit |
Device | Inari Medical, Inc., Stryker Corporation | $73.95 | 2 | 2025 |
Source payment records
|
|||||
| FLOWTRIEVER CATHETER, S Normalized: flowtriever catheter s |
Device | Inari Medical, Inc., Stryker Corporation | $73.95 | 2 | 2025 |
Source payment records
|
|||||
| General - Atherectomy Normalized: general atherectomy |
Device | Boston Scientific Corporation | $56.75 | 1 | 2025 |
Source payment records
|
|||||
| VASHE WOUND SOLUTION 250 ML (8.5 FL OZ) FLIP TOP CAP Normalized: vashe wound solution 250 ml 8 5 fl oz flip top cap |
Device | Urgo Medical North America, LLC | $53.57 | 2 | 2025 |
Source payment records
|
|||||
| DAYSPRING Normalized: dayspring |
Device | Koya Medical, Inc. | $53.43 | 3 | 2025 |
Source payment records
|
|||||
| KOYA MEDICAL Normalized: koya medical |
Device | Koya Medical, Inc. | $53.43 | 3 | 2025 |
Source payment records
|
|||||
| VIABAHN Endoprosthesis with PROPATEN Bioactive Surface Normalized: viabahn endoprosthesis with propaten bioactive surface |
Device | W. L. Gore & Associates, Inc. | $47.85 | 2 | 2025 |
Source payment records
|
|||||
| GRAFIX Normalized: grafix |
Biological | Smith+Nephew, Inc. | $46.67 | 1 | 2025 |
Source payment records
|
|||||
| STRAVIX Normalized: stravix |
Biological | Smith+Nephew, Inc. | $46.67 | 1 | 2025 |
Source payment records
|
|||||
| CYGNUS DUAL Normalized: cygnus dual |
Medical Supply | Organogenesis Inc. | $44.71 | 1 | 2025 |
Source payment records
|
|||||
| ELLIPSYS VASCULAR ACCESS SYSTEM Normalized: ellipsys vascular access system |
Device | Medtronic, Inc. | $43.17 | 6 | 2025 |
Source payment records
|
|||||
| VENASEAL Normalized: venaseal |
Device | Medtronic, Inc. | $39.84 | 7 | 2025 |
Source payment records
|
|||||
| PROTEGE GPS Normalized: protege gps |
Device | Medtronic, Inc. | $38.80 | 1 | 2025 |
Source payment records
|
|||||
| ELUVIA Normalized: eluvia |
Device | Boston Scientific Corporation | $36.50 | 1 | 2025 |
Source payment records
|
|||||
| EXCLUDER Conformable AAA Endoprosthesis with Active Control Normalized: excluder conformable aaa endoprosthesis with active control |
Device | W. L. Gore & Associates, Inc. | $35.28 | 1 | 2025 |
Source payment records
|
|||||
| Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter Normalized: shockwave ivl system with the shockwave c2 coronary ivl catheter |
Device | Shockwave Medical, Inc | $33.69 | 1 | 2025 |
Source payment records
|
|||||
| GORE VIABAHN Endoprosthesis Normalized: gore viabahn endoprosthesis |
Device | W. L. Gore & Associates, Inc. | $31.27 | 1 | 2025 |
Source payment records
|
|||||
| NANOCROSS ELITE Normalized: nanocross elite |
Device | Medtronic, Inc. | $25.78 | 1 | 2025 |
Source payment records
|
|||||
| Flexitouch Plus Normalized: flexitouch plus |
Device | Tactile Systems Technology Inc | $25.55 | 1 | 2025 |
Source payment records
|
|||||
| Nimbl Normalized: nimbl |
Device | Tactile Systems Technology Inc | $25.55 | 1 | 2025 |
Source payment records
|
|||||
| Athletis Normalized: athletis |
Device | Boston Scientific Corporation | $25.20 | 1 | 2025 |
Source payment records
|
|||||
| MYNX CONTROL Normalized: mynx control |
Device | CORDIS US CORP. | $25.13 | 1 | 2025 |
Source payment records
|
|||||
| HAWKONE Normalized: hawkone |
Device | Medtronic, Inc. | $25.05 | 1 | 2025 |
Source payment records
|
|||||
| IN.PACT AV Normalized: in pact av |
Device | Medtronic, Inc. | $23.93 | 1 | 2025 |
Source payment records
|
|||||
| ABRE Normalized: abre |
Device | Medtronic, Inc. | $23.31 | 1 | 2025 |
Source payment records
|
|||||
| CLOTTRIEVER BOLD CATHETER Normalized: clottriever bold catheter |
Device | Stryker Corporation | $22.13 | 1 | 2025 |
Source payment records
|
|||||
| GORE EXCLUDER AAA Endoprosthesis Normalized: gore excluder aaa endoprosthesis |
Device | W. L. Gore & Associates, Inc. | $21.61 | 1 | 2025 |
Source payment records
|
|||||
| SPIDERFX Normalized: spiderfx |
Device | Medtronic, Inc. | $20.01 | 1 | 2025 |
Source payment records
|
|||||
| TORNADO Normalized: tornado |
Device | Cook Medical LLC | $17.62 | 1 | 2025 |
Source payment records
|
|||||
| OMNILINK ELITE Normalized: omnilink elite |
Device | Abbott Laboratories | $13.84 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Clopidogrel | Clopidogrel Bisulfate | 58 | 29 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 37 | 31 |
| Xarelto | Rivaroxaban | 15 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $3,248.16 · 89 records | Abbott Laboratories | ABRE, AURYON LASER SYSTEM 100-120 VAC, Athletis, CLOTTRIEVER BOLD CATHETER, COVERA, CT THROMBECTOMY SYSTEM KIT, CYGNUS DUAL, DAYSPRING, DIAMONDBACK PERIPHERAL, ELLIPSYS VASCULAR ACCESS SYSTEM, ELUVIA, ESPRIT, EXCLUDER Conformable AAA Endoprosthesis with Active Control, FLOWTRIEVER CATHETER, S, Flexitouch Plus, GORE EXCLUDER AAA Endoprosthesis, GORE VIABAHN Endoprosthesis, GRAFIX, General - Atherectomy, General - Vascular Intervention, HAWKONE, IN.PACT ADMIRAL, IN.PACT AV, Indigo System, KOYA MEDICAL, MYNX CONTROL, NANOCROSS ELITE, Nimbl, OMNILINK ELITE, PROTEGE GPS, Penumbra System, RotarexS 6 F x 135 cm, SPIDERFX, STRAVIX, Serrantor, Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter, TORNADO, TURBOHAWK, VASHE WOUND SOLUTION 250 ML (8.5 FL OZ) FLIP TOP CAP, VENASEAL, VIABAHN Endoprosthesis with PROPATEN Bioactive Surface | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error